lung adenocarcinoma
Lung Cancer Progression, Prognostic Features Investigated in Proteogenomic Studies
Two independent research teams turned to proteogenomics to parse out the transition from pre-invasive to invasive lung adenocarcinoma and to assess small cell lung cancer.
In New TRACERx Data, Personalis MRD Test Shows Improved Sensitivity With Potential Clinical Impact
Premium
The data, some of the first available for the firm's NeXT Personal test, indicated that its higher analytical sensitivity could lead to better risk prediction than competing tests.
Intra-Tumor Heterogeneity Patterns Correlate With Survival in Lung Cancer Patients
The researchers uncovered two distinct spatial patterns within lung adenocarcinoma using both proteomic and genomic approaches.
Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients
Lilly will cover the cost of Tempus' broad-based sequencing tests for advanced non-small cell lung cancer patients to improve biomarker testing access.
Blood Lipid Mass Spectrometry Assay May Enable Early-Stage Lung Cancer Detection
Researchers in China have come up with a machine learning- and lipidomics-based strategy for detecting lung cancer early in blood samples.